HSPA1A and neoplasm: To corroborate these findings, we pharmacologically inhibited the activity of Hsp70 by treating A549 and H1299 tumor cells with increased concentrations of VER-155008 for 24 h, a selective and potent inhibitor of Hsp70 function, by competitively binding its ATPase binding domain [34].